The number of Americans who are exploring the concept of better living through antidepressant chemistry nearly doubled in the decade from 1996 to 2005, according to a study published in Archives of General Psychiatry—and that was well before the economic meltdown.
Among users of antidepressants, the percentage receiving psychotherapy fell from 31.5% to less than 20%, the study says. About 80% of patients were treated by doctors other than psychiatrists.
Patients today may be more likely to ask about antidepressant advertising, says study author Mark Olfson of Columbia University and the New York State Psychiatric Institute. During the study, spending on direct-to-consumer antidepressant ads increased from $32 million to $122 million.